Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?

Treatment of patients with primary biliary cirrhosis (PBC) using ursodeoxycholic acid (UDCA) leads to a reduction in serum bilirubin. The first objective of this study was to assess the performance of certain prognostic indicators for PBC after the introduction of treatment with UDCA. Serum bilirubin is an important prognostic indicator for PBC and an important component of the Mayo model for grading patients into risk categories. In an analysis of patients enrolled in the Canadian multicenter trial, the Mayo score was calculated before and after treatment with UDCA. After treatment, the Mayo score continued to divide patients with PBC into groups with varying risk. In addition, the serum bilirubin alone was shown to do the same even after the introduction of treatment with UDCA. A second objective was to establish whether UDCA had an effect on long‐term (2‐ to 6‐year) survival in patients with PBC.

[1]  E. Dickson,et al.  Combined analysis of French, American and Canadian randomized controlled trials of ursodeoxycholic acid therapy in primary biliary cirrhosis , 1995 .

[2]  P. Grambsch,et al.  Primary biliary cirrhosis: Prediction of short‐term survival based on repeated patient visits , 1994, Hepatology.

[3]  B. Balkau,et al.  Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. , 1994, The New England journal of medicine.

[4]  E. Dickson,et al.  Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. , 1994, Gastroenterology.

[5]  U. Steinbrecher,et al.  The canadian multicenter double‐blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis , 1994, Hepatology.

[6]  M. Bennett,et al.  A two year controlled trial examining the effectiveness of ursodeoxycholic acid in primary biliary cirrhosis , 1994, Journal of gastroenterology and hepatology.

[7]  B. Balkau,et al.  Predictive factors in ursodeoxycholic acid‐treated patients with primary biliary Cirrhosis: Role of serum markers of connective tissue , 1994, Hepatology.

[8]  D G Altman,et al.  Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. PBC1 and PBC2 trial groups. , 1993, Gastroenterology.

[9]  A. West,et al.  A randomized, double‐blind, placebo‐controlled trial of ursodeoxycholic acid in primary biliary cirrhosis , 1993, Hepatology.

[10]  F. Bianchi,et al.  Ursodeoxycholic acid for symptomatic primary biliary cirrhosis. Preliminary analysis of a double-blind multicenter trial. Italian Multicenter Group for the Study of UDCA in PBC. , 1993, Journal of hepatology.

[11]  B. Balkau,et al.  A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. , 1991, The New England journal of medicine.

[12]  J. Neuberger,et al.  Referral of patients with primary biliary cirrhosis for liver transplantation. , 1990, Gut.

[13]  G. Bonsel,et al.  Use of prognostic models for assessment of value of liver transplantation in primary biliary cirrhosis , 1990, The Lancet.

[14]  K. Hübner,et al.  Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial. , 1989, Gastroenterology.

[15]  P. Grambsch,et al.  Prognosis in primary biliary cirrhosis: Model for decision making , 1989, Hepatology.

[16]  D. Altman,et al.  Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial. , 1985, Gastroenterology.

[17]  D. Altman,et al.  Beneficial Effect of Azathioprine and Prediction of Prognosis in Primary Biliary , 1985 .

[18]  J. Boyer,et al.  The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis. , 1983, The New England journal of medicine.

[19]  F. Schaffner,et al.  Serum bilirubin: a prognostic factor in primary biliary cirrhosis. , 1979, Gut.

[20]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .